guanfacine
Sign in to saveKey facts
- Drug.Verifiedfields
- changed
- Drug.verifiedrevid
- 461124228
- Drug.image
- Guanfacine.svg
- Drug.image_class
- skin-invert-image
- Drug.image2
- Guanfacine 3d ball stick.png
- Drug.image_class2
- bg-transparent
- Drug.width2
- 270
- Drug.tradename
- Intuniv, others
- Drug.MedlinePlus
- a601059
- Drug.DailyMedID
- Guanfacine
- Drug.routes_of_administration
- By mouth
- Drug.class
- α2A-adrenergic receptor agonist
- Drug.ATC_prefix
- C02
- Drug.ATC_suffix
- AC02
- Drug.legal_AU
- S4
- Drug.legal_CA
- Rx-only
- Drug.legal_US
- Rx-only
- Drug.legal_EU
- Rx-only
via Wikipedia infobox
Article
13 sectionsContents
- Medical uses
- Adverse effects
- Interactions
- Pharmacology
- Pharmacodynamics
- Pharmacokinetics
- Preparation
- History
- Society and culture
- Legal status
- Brand names
- Research
- References
Guanfacine, sold under the brand name Tenex (immediate-release) and Intuniv (extended-release) among others, is an oral alpha-2a agonist medication used to treat attention deficit hyperactivity disorder (ADHD) and high blood pressure.
Common side effects include sleepiness, constipation, and dry mouth. Other side effects may include low blood pressure and urinary problems. It appears to work by activating α2A-adrenergic receptors in the brain, thereby decreasing sympathetic nervous system activity.
Gallery (3)
Connections
Categories
5-HT2B agonistsAcylguanidinesAlpha2-adrenergic agonistsAntihypertensive agentsAttention deficit hyperactivity disorder managementChloroarenesChlorobenzene derivativesDrugboxes which contain changes to verified fieldsDrugs developed by Takeda Pharmaceutical CompanyDrugs with non-standard legal statusECHA InfoCard ID from WikidataExperimental anxiolytics